NEUROLASER

GOAL

Evaluation of the efficacy of photobiomodulation (PBM) therapy in the prevention of chemotherapy-induced neuropathy in breast cancer patients

STUDY DESIGN

Placebo-controlled, randomized trial with breast cancer patients who underwent neurotoxic chemotherapy at the Jessa Hospital (NCT03391271) from December 2017 until November 2021. 

Control group (n=16)	Laser group (n=16)
Chemotherapy	​Chemotherapy
Placebo treatment (2x/week, during chemotherapy period)	PBM (2x/week, during chemotherapy period)

STUDY RESULTS

Results are currently analysed. 

PUBLICATIONS

 

PARTNERS